{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37139479", "DateRevised": {"Year": "2023", "Month": "05", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "24"}], "Language": ["eng"], "ELocationID": ["7598307", "10.1155/2023/7598307"], "Journal": {"ISSN": "1687-708X", "JournalIssue": {"Volume": "2023", "PubDate": {"Year": "2023"}}, "Title": "Interdisciplinary perspectives on infectious diseases", "ISOAbbreviation": "Interdiscip Perspect Infect Dis"}, "ArticleTitle": "A Brief Review on Medicinal Plants-At-Arms against COVID-19.", "Pagination": {"StartPage": "7598307", "MedlinePgn": "7598307"}, "Abstract": {"AbstractText": ["COVID-19 pandemic caused by the novel SARS-CoV-2 has impacted human livelihood globally. Strenuous efforts have been employed for its control and prevention; however, with recent reports on mutated strains with much higher infectivity, transmissibility, and ability to evade immunity developed from previous SARS-CoV-2 infections, prevention alternatives must be prepared beforehand in case. We have perused over 128 recent works (found on Google Scholar, PubMed, and ScienceDirect as of February 2023) on medicinal plants and their compounds for anti-SARS-CoV-2 activity and eventually reviewed 102 of them. The clinical application and the curative effect were reported high in China and in India. Accordingly, this review highlights the unprecedented opportunities offered by medicinal plants and their compounds, candidates as the therapeutic agent, against COVID-19 by acting as viral protein inhibitors and immunomodulator in (32 clinical trials and hundreds of <i>in silico</i> experiments) conjecture with modern science. Moreover, the associated foreseeable challenges for their viral outbreak management were discussed in comparison to synthetic drugs."], "CopyrightInformation": "Copyright \u00a9 2023 Shivani Srivastava et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Mycorrhizal Research, Sustainable Agriculture Division, The Energy and Resources Institute (TERI), TERI Gram, Gwal Pahari, Gurugram 122001, India."}], "LastName": "Srivastava", "ForeName": "Shivani", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Songshan Lake Materials Laboratory, University Innovation Park, Dongguan 523-808, China."}], "LastName": "He", "ForeName": "Fangzhou", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Songshan Lake Materials Laboratory, University Innovation Park, Dongguan 523-808, China."}], "LastName": "Huang", "ForeName": "Yuanding", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Medical University, Shenyang, China."}], "LastName": "Niu", "ForeName": "Meng", "Initials": "M"}, {"Identifier": ["0000-0002-8116-8045"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Mycorrhizal Research, Sustainable Agriculture Division, The Energy and Resources Institute (TERI), TERI Gram, Gwal Pahari, Gurugram 122001, India."}], "LastName": "Adholeya", "ForeName": "Alok", "Initials": "A"}, {"Identifier": ["0000-0002-7984-9319"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Songshan Lake Materials Laboratory, University Innovation Park, Dongguan 523-808, China."}], "LastName": "Peng", "ForeName": "Weng Kung", "Initials": "WK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "Interdiscip Perspect Infect Dis", "NlmUniqueID": "101496545", "ISSNLinking": "1687-708X"}, "CoiStatement": "The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Worldometer. Covid-19 Coronavirus Pandemic . London, UK: Worldometer; 2023."}, {"Citation": "Kumar A., Gupta P. K., Srivastava A. A review of modern technologies for tackling COVID-19 pandemic. Diabetes and Metabolic Syndrome: Clinical Research Reviews . 2020;14(4):569\u2013573. doi: 10.1016/j.dsx.2020.05.008.", "ArticleIdList": ["10.1016/j.dsx.2020.05.008", "PMC7204706", "32413821"]}, {"Citation": "Bashir M. F., Ma B. J., Komal B., et al. Correlation between environmental pollution indicators and COVID-19 pandemic: a brief study in Californian context. Environmental Research . 2020;187 doi: 10.1016/j.envres.2020.109652.109652", "ArticleIdList": ["10.1016/j.envres.2020.109652", "PMC7219392", "32405084"]}, {"Citation": "Liu M., Han Y., Sun J., et al. Comparison of the epidemiological and clinical characteristics of hospitalized children with pneumonia caused by SARS-CoV-2, influenza A, and human adenoviruses: a case-control study. Clinical Pediatrics . 2022;61(2):150\u2013158. doi: 10.1177/00099228211058601.", "ArticleIdList": ["10.1177/00099228211058601", "34753343"]}, {"Citation": "Matveeva O., Ershov A. Retrospective cohort study of the effectiveness of the sputnik V and EpiVacCorona vaccines against the SARS-CoV-2 delta variant in moscow (June\u2013July 2021) Vaccines . 2022;10(7):p. 984. doi: 10.3390/vaccines10070984.", "ArticleIdList": ["10.3390/vaccines10070984", "PMC9320764", "35891148"]}, {"Citation": "Cruz C., Silva A. R., Rezende C. M., Santos M. J. C., Fabris J. P. Vacinas ccupidcm. Revista FSA . 2021;18(6):203\u2013222. doi: 10.12819/2021.18.6.11.", "ArticleIdList": ["10.12819/2021.18.6.11"]}, {"Citation": "Baden L. R., El Sahly H. M., Essink B., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine . 2021;384(5):403\u2013416. doi: 10.1056/nejmoa2035389.", "ArticleIdList": ["10.1056/nejmoa2035389", "PMC7787219", "33378609"]}, {"Citation": "Teo S. P. Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273. Journal of Pharmacy Practice . 2022;35(6):947\u2013951. doi: 10.1177/08971900211009650.", "ArticleIdList": ["10.1177/08971900211009650", "33840294"]}, {"Citation": "Polack F. P., Thomas S. J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine . 2020;383(27):2603\u20132615. doi: 10.1056/nejmoa2034577.", "ArticleIdList": ["10.1056/nejmoa2034577", "PMC7745181", "33301246"]}, {"Citation": "Li J., Hou L., Guo X., et al. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nature Medicine . 2022;28(2):401\u2013409. doi: 10.1038/s41591-021-01677-z.", "ArticleIdList": ["10.1038/s41591-021-01677-z", "PMC8863573", "35087233"]}, {"Citation": "Ghiasi N., Valizadeh R., Arabsorkhi M., et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa . 2021;7(2):p. e31. doi: 10.34172/ipp.2021.31.", "ArticleIdList": ["10.34172/ipp.2021.31"]}, {"Citation": "Shay D. K., Gee J., Su J. R., et al. Safety monitoring of the janssen (johnson & johnson) COVID-19 vaccine \u2014 United States, march\u2013april 2021. MMWR. Morbidity and Mortality Weekly Report . 2021;70(18):680\u2013684. doi: 10.15585/mmwr.mm7018e2.", "ArticleIdList": ["10.15585/mmwr.mm7018e2", "PMC9368748", "33956784"]}, {"Citation": "Hung I. F. N., Poland G. A. Single-dose Oxford\u2013AstraZeneca COVID-19 vaccine followed by a 12-week booster. The Lancet . 2021;397(10277):854\u2013855. doi: 10.1016/s0140-6736(21)00528-6.", "ArticleIdList": ["10.1016/s0140-6736(21)00528-6", "PMC8086170", "33676614"]}, {"Citation": "Sapkal G. N., Yadav P. D., Ella R., et al. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2. Journal of Travel Medicine . 2021;28(4) doi: 10.1093/jtm/taab051.taab051", "ArticleIdList": ["10.1093/jtm/taab051", "PMC8083765", "33772577"]}, {"Citation": "Wang H., Zhang Y., Huang B., et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell . 2020;182(3):713\u2013721. doi: 10.1016/j.cell.2020.06.008.", "ArticleIdList": ["10.1016/j.cell.2020.06.008", "PMC7275151", "32778225"]}, {"Citation": "Wang J., Jing R., Lai X., et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines . 2020;8(3):p. 482. doi: 10.3390/vaccines8030482.", "ArticleIdList": ["10.3390/vaccines8030482", "PMC7565574", "32867224"]}, {"Citation": "Lu L., Mok B. W. Y., Chen L. L., et al. Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients. Clinical Infectious Diseases . 2022;75(1):e822\u2013e826. doi: 10.1093/cid/ciab1041.", "ArticleIdList": ["10.1093/cid/ciab1041", "PMC8754807", "34915551"]}, {"Citation": "Kiem C. T., Andronico A., Bosetti P. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study. Euro Surveillance . 2021;26(26)2100533", "ArticleIdList": ["PMC8326661", "34212840"]}, {"Citation": "Parums D. V. Editorial: first approval of the protein-based adjuvanted nuvaxovid (NVX-CoV2373) novavax vaccine for SARS-CoV-2 could increase vaccine uptake and provide immune protection from viral variants. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research . 2022;28:936523\u2013936521. doi: 10.12659/MSM.936523.", "ArticleIdList": ["10.12659/MSM.936523", "PMC8897963", "35228506"]}, {"Citation": "Meo S. A., Bukhari I. A., Akram J., Meo A. S., Klonoff D. C. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. European Review for Medical and Pharmacological Sciences . 2021;25(3):1663\u20131669. doi: 10.26355/eurrev_202102_24877.", "ArticleIdList": ["10.26355/eurrev_202102_24877", "33629336"]}, {"Citation": "Mahase E. Covid-19: Pfizer and BioNTech Submit Vaccine for US Authorisation . London, UK: British Medical Journal Publishing Group; 2020.", "ArticleIdList": ["33219049"]}, {"Citation": "Guzm\u00e1n-Mart\u00ednez O., Guardado K., de Guevara E. L., et al. IgG antibodies generation and side effects caused by Ad5-nCoV vaccine (CanSino Biologics) and BNT162b2 vaccine (Pfizer/BioNTech) among Mexican population. Vaccines . 2021;9(9):p. 999. doi: 10.3390/vaccines9090999.", "ArticleIdList": ["10.3390/vaccines9090999", "PMC8473118", "34579236"]}, {"Citation": "Nainwal L. M. Coronavirus Drug Discovery . Amsterdam, The Netherland: Elsevier; 2022. FDA Coronavirus Treatment Acceleration Program: approved drugs and those in clinical trials; pp. 249\u2013264."}, {"Citation": "Rizk J. G., Forthal D. N., Kalantar-Zadeh K., et al. Expanded access programs, compassionate drug use, and emergency use authorizations during the COVID-19 pandemic. Drug Discovery Today . 2021;26(2):593\u2013603. doi: 10.1016/j.drudis.2020.11.025.", "ArticleIdList": ["10.1016/j.drudis.2020.11.025", "PMC7694556", "33253920"]}, {"Citation": "Ledford H. Coronavirus Breakthrough: Dexamethasone Is First Drug Shown to Save Lives . London, UK: Nature Publishing Group; 2020.", "ArticleIdList": ["32546811"]}, {"Citation": "Hansen C. H., Michlmayr D., Gubbels S. M., Molbak K., Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. The Lancet . 2021;397(10280):1204\u20131212. doi: 10.1016/s0140-6736(21)00575-4.", "ArticleIdList": ["10.1016/s0140-6736(21)00575-4", "PMC7969130", "33743221"]}, {"Citation": "Madhi S. A., Baillie V., Cutland C. L. Efficacy of the ChAdOx1 nCoV-19 and Covid-19 vaccine against the B. 1.351 variant. New England Journal of Medicine . 2021;384(20):1885\u20131898.", "ArticleIdList": ["PMC7993410", "33725432"]}, {"Citation": "Grint D. J., Wing K., Williamson E., et al. Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February. Euro Surveillance . 2021;26(11) doi: 10.2807/1560-7917.es.2021.26.11.2100256.2100256", "ArticleIdList": ["10.2807/1560-7917.es.2021.26.11.2100256", "PMC7976383", "33739254"]}, {"Citation": "Forni G., Mantovani A. COVID-19 vaccines: where we stand and challenges ahead. Cell Death & Differentiation . 2021;28(2):626\u2013639. doi: 10.1038/s41418-020-00720-9.", "ArticleIdList": ["10.1038/s41418-020-00720-9", "PMC7818063", "33479399"]}, {"Citation": "Ilango S., Sahoo D. K., Paital B., et al. A review on annona muricata and its anticancer activity. Cancers . 2022;14(18):p. 4539. doi: 10.3390/cancers14184539.", "ArticleIdList": ["10.3390/cancers14184539", "PMC9497149", "36139697"]}, {"Citation": "Chhabria S., Mathur S., Vadakan S., Sahoo D. K., Mishra P., Paital B. A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity. Frontiers in Endocrinology . 2022;13 doi: 10.3389/fendo.2022.1027237.1027237", "ArticleIdList": ["10.3389/fendo.2022.1027237", "PMC9691845", "36440220"]}, {"Citation": "Vishwakarma R. Redeploying plant defences. Nature Plants . 2020;6(3):p. 177.", "ArticleIdList": ["PMC7091691", "32170291"]}, {"Citation": "Huang Y.-F., Bai C., He F., Xie Y., Zhou H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19) Pharmacological Research . 2020;158 doi: 10.1016/j.phrs.2020.104939.104939", "ArticleIdList": ["10.1016/j.phrs.2020.104939", "PMC7239792", "32445956"]}, {"Citation": "Vandebroek I., Pieroni A., Stepp J. R., et al. Reshaping the future of ethnobiology research after the COVID-19 pandemic. Nature Plants . 2020;6(7):723\u2013730. doi: 10.1038/s41477-020-0691-6.", "ArticleIdList": ["10.1038/s41477-020-0691-6", "32572213"]}, {"Citation": "Sampangi-Ramaiah M. H., Vishwakarma R., Uma Shaanker R. Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Current Science . 2020;118(7):p. 1087. doi: 10.18520/cs/v118/i7/1087-1092.", "ArticleIdList": ["10.18520/cs/v118/i7/1087-1092"]}, {"Citation": "Mishra A. K., Tewari S. P. Silico screening of some naturally occurring bioactive compounds predicts potential inhibitors against SARS-COV-2 (COVID-19) protease. 2004.  \n https://arxiv.org/abs/2004.01634\n."}, {"Citation": "Islam R., Parves M. R., Paul A. S., et al. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3213\u20133224. doi: 10.1080/07391102.2020.1761883.", "ArticleIdList": ["10.1080/07391102.2020.1761883", "PMC7232885", "32340562"]}, {"Citation": "Enmozhi S. K., Raja K., Sebastine I., Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3092\u20133098. doi: 10.1080/07391102.2020.1760136.", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Joshi R. S., Jagdale S. S., Bansode S. B., et al. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3099\u20133114. doi: 10.1080/07391102.2020.1760137.", "ArticleIdList": ["10.1080/07391102.2020.1760137", "PMC7212545", "32329408"]}, {"Citation": "Kundu D., Selvaraj C., Singh S. K., Dubey V. K. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3428\u20133434. doi: 10.1080/07391102.2020.1763202.", "ArticleIdList": ["10.1080/07391102.2020.1763202", "PMC7232883", "32362243"]}, {"Citation": "Pandit M., Latha N. Silico Studies Reveal Potential Antiviral Activity of Phytochemicals trom Medicinal Plants for the Treatment of Covid-19 Infection . Durham, NC, USA: Research Square Platform LLC; 2020."}, {"Citation": "Chen H., Du Q. Potential Natural Compounds for Preventing Sars-Cov-2 (2019-Ncov) Infection . Durham, NC, USA: Research Square Platform LLC; 2020."}, {"Citation": "Tallei T. E., Tumilaar S. G., Niode N. J., et al. Potential of plant bioactive compounds as SARS-CoV-2 main protease (mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Scientific . 2020;2020:18. doi: 10.1155/2020/6307457.6307457", "ArticleIdList": ["10.1155/2020/6307457", "PMC7773461", "33425427"]}, {"Citation": "Gurung A. B., Ali M. A., Lee J., Farah M. A., Al-Anazi K. M. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sciences . 2020;255 doi: 10.1016/j.lfs.2020.117831.117831", "ArticleIdList": ["10.1016/j.lfs.2020.117831", "PMC7243810", "32450166"]}, {"Citation": "Aanouz I., Belhassan A., El-Khatabi K., Lakhlifi T., El-ldrissi M., Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations. Journal of Biomolecular Structure and Dynamics . 2021;39(8):2971\u20132979. doi: 10.1080/07391102.2020.1758790.", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Gyebi G. A., Ogunro O. B., Adegunloye A. P. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3396\u20133408.", "ArticleIdList": ["PMC7256353", "32367767"]}, {"Citation": "Yu J., Wang L., Bao L. Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method. Journal of Functional Foods . 2020;71 doi: 10.1016/j.jff.2020.104016.104016", "ArticleIdList": ["10.1016/j.jff.2020.104016", "PMC7225714", "32421102"]}, {"Citation": "Zhang Z., Wu W., Hou J., et al. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC\u2013MSE analysis. Journal of integrative medicine . 2020;18(3):229\u2013241. doi: 10.1016/j.joim.2020.03.004.", "ArticleIdList": ["10.1016/j.joim.2020.03.004", "PMC7195604", "32307268"]}, {"Citation": "Dubey K., Dubey R. Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor. Biomedical Journal . 2020;43(4):363\u2013367. doi: 10.1016/j.bj.2020.05.002.", "ArticleIdList": ["10.1016/j.bj.2020.05.002", "PMC7233213", "32426388"]}, {"Citation": "Peele K. A., Potla Durthi C., Srihansa T., et al. Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: a computational study. Informatics in Medicine Unlocked . 2020;19 doi: 10.1016/j.imu.2020.100345.100345", "ArticleIdList": ["10.1016/j.imu.2020.100345", "PMC7211761", "32395606"]}, {"Citation": "Yu R., Chen L., Lan R., Shen R., Li P. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. International Journal of Antimicrobial Agents . 2020;56(2) doi: 10.1016/j.ijantimicag.2020.106012.106012", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106012", "PMC7205718", "32389723"]}, {"Citation": "Sudeep H., Gouthamchandra K., Shyamprasad K. Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) in comparison with the COVID-19 main protease. Bioinformation . 2020;16(5):411\u2013417. doi: 10.6026/97320630016411.", "ArticleIdList": ["10.6026/97320630016411", "PMC7434955", "32831523"]}, {"Citation": "Bhardwaj V. K., Singh R., Sharma J., Rajendran V., Purohit R., Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics . 2021;39(10):3449\u20133458. doi: 10.1080/07391102.2020.1766572.", "ArticleIdList": ["10.1080/07391102.2020.1766572", "PMC7256349", "32397940"]}, {"Citation": "Kumar A., Choudhir G., Shukla S. K., et al. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics . 2021;39(10):3760\u20133770. doi: 10.1080/07391102.2020.1772112.", "ArticleIdList": ["10.1080/07391102.2020.1772112", "PMC7284142", "32448034"]}, {"Citation": "Da Silva J. K. R., Figueiredo P. L. B., Byler K. G., Setzer W. N. Essential oils as antiviral agents, potential of essential oils to treat SARS-CoV-2 infection: an in-silico investigation. International Journal of Molecular Sciences . 2020;21(10):p. 3426. doi: 10.3390/ijms21103426.", "ArticleIdList": ["10.3390/ijms21103426", "PMC7279430", "32408699"]}, {"Citation": "Gupta M. K., Vemula S., Donde R., Gouda G., Behera L., Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics . 2021;39(7):2617\u20132627. doi: 10.1080/07391102.2020.1751300.", "ArticleIdList": ["10.1080/07391102.2020.1751300", "PMC7171389", "32238078"]}, {"Citation": "Abdelli I., Hassani F., Bekkel Brikci S., Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics . 2021;39(9):3263\u20133276. doi: 10.1080/07391102.2020.1763199.", "ArticleIdList": ["10.1080/07391102.2020.1763199", "PMC7232889", "32362217"]}, {"Citation": "Lung J., Lin Y. S., Yang Y. H., et al. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. Journal of Medical Virology . 2020;92(6):693\u2013697. doi: 10.1002/jmv.25761.", "ArticleIdList": ["10.1002/jmv.25761", "PMC7228302", "32167173"]}, {"Citation": "Ahmad S., Abbasi H. W., Shahid S., Gul S., Abbasi S. W. Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment. Journal of Biomolecular Structure and Dynamics . 2021;39(12):4225\u20134233. doi: 10.1080/07391102.2020.1775129.", "ArticleIdList": ["10.1080/07391102.2020.1775129", "PMC7298883", "32462996"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R. Potential inhibitor of COVID-19 main protease (mpro) from several medicinal plant compounds by molecular docking study. Preprints . 2020:1\u201314. doi: 10.20944/preprints202003.0226.v1.20944", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Bugin K., Woodcock J. Trends in COVID-19 therapeutic clinical trials. Nature Reviews Drug Discovery . 2021;20(4):254\u2013255. doi: 10.1038/d41573-021-00037-3.", "ArticleIdList": ["10.1038/d41573-021-00037-3", "33633370"]}, {"Citation": "He Y., Yang J., Lv Y., et al. A review of ginseng clinical trials registered in the WHO international clinical trials registry platform. BioMed Research International . 2018;2018:7. doi: 10.1155/2018/1843142.1843142", "ArticleIdList": ["10.1155/2018/1843142", "PMC5818925", "29546050"]}, {"Citation": "Al-Kuraishy H. M., Al-Fakhrany O. M., Elekhnawy E., et al. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic. European Journal of Medical Research . 2022;27(1):p. 186. doi: 10.1186/s40001-022-00818-5.", "ArticleIdList": ["10.1186/s40001-022-00818-5", "PMC9510171", "36154838"]}, {"Citation": "Peiris J. S. M., Guan Y., Yuen K. Y. Severe acute respiratory syndrome. Nature Medicine . 2004;10(12):S88\u2013S97. doi: 10.1038/nm1143.", "ArticleIdList": ["10.1038/nm1143", "PMC7096017", "15577937"]}, {"Citation": "Luo H., Tang Q., Shang Y., et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrative Medicine . 2020;26(4):243\u2013250. doi: 10.1007/s11655-020-3192-6.", "ArticleIdList": ["10.1007/s11655-020-3192-6", "PMC7088641", "32065348"]}, {"Citation": "Li F.-S., Weng J.-K. Demystifying traditional herbal medicine with modern approach. Nature Plants . 2017;3(8):17109\u201317117. doi: 10.1038/nplants.2017.109.", "ArticleIdList": ["10.1038/nplants.2017.109", "28758992"]}, {"Citation": "Wang L., Yan B., Boasson V. A national fight against COVID\u201019: lessons and experiences from China. Australian & New Zealand Journal of Public Health . 2020;44(6):502\u2013507. doi: 10.1111/1753-6405.13042.", "ArticleIdList": ["10.1111/1753-6405.13042", "PMC7675353", "33044796"]}, {"Citation": "Rastogi S., Pandey D. N., Singh R. H. COVID-19 pandemic: a pragmatic plan for ayurveda intervention. Journal of Ayurveda and Integrative Medicine . 2022;13(1) doi: 10.1016/j.jaim.2020.04.002.100312", "ArticleIdList": ["10.1016/j.jaim.2020.04.002", "PMC7177084", "32382220"]}, {"Citation": "Huang J., Tao G., Liu J., Cai J., Huang Z., Chen J. Current prevention of COVID-19: natural products and herbal medicine. Frontiers in Pharmacology . 2020;11 doi: 10.3389/fphar.2020.588508.588508", "ArticleIdList": ["10.3389/fphar.2020.588508", "PMC7597394", "33178026"]}, {"Citation": "Balachandran I. Chemical profiling of selected Ayurveda formulations recommended for COVID-19. Beni-Suef University Journal of Basic and Applied Sciences . 2021;10(1):2\u20135. doi: 10.1186/s43088-020-00089-1.", "ArticleIdList": ["10.1186/s43088-020-00089-1", "PMC7799399", "33457430"]}, {"Citation": "Li S.., Chen C., Zhang H.., et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Research . 2005;67(1):18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Lau K.-M., Lee K.-M., Koon C.-M., et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. Journal of Ethnopharmacology . 2008;118(1):79\u201385. doi: 10.1016/j.jep.2008.03.018.", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Lin C.-W., Tsai F.-J., Tsai C.-H., et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research . 2005;68(1):36\u201342. doi: 10.1016/j.antiviral.2005.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Ryu Y. B., Jeong H. J., Kim J. H., et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorganic and Medicinal Chemistry . 2010;18(22):7940\u20137947. doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Bhuiyan F. R., Howlader S., Raihan T., Hasan M. Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic. Frontiers of Medicine . 2020;7:p. 444. doi: 10.3389/fmed.2020.00444.", "ArticleIdList": ["10.3389/fmed.2020.00444", "PMC7427128", "32850918"]}, {"Citation": "Gupta A., Madhavan M. V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nature Medicine . 2020;26(7):1017\u20131032. doi: 10.1038/s41591-020-0968-3.", "ArticleIdList": ["10.1038/s41591-020-0968-3", "32651579"]}, {"Citation": "Tay M. Z., Poh C. M., R\u00e9nia L., MacAry P. A., Ng L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology . 2020;20(6):363\u2013374. doi: 10.1038/s41577-020-0311-8.", "ArticleIdList": ["10.1038/s41577-020-0311-8", "PMC7187672", "32346093"]}, {"Citation": "Dutta A., Roy A., Roy L., Chattopadhyay S., Chatterjee S. Immune response and possible therapeutics in COVID-19. RSC Advances . 2021;11(2):960\u2013977. doi: 10.1039/d0ra08901j.", "ArticleIdList": ["10.1039/d0ra08901j", "PMC8693424", "35423713"]}, {"Citation": "Busse L. W., Chow J. H., McCurdy M. T. COVID-19 and the RAAS\u2014A Potential Role for Angiotensin II? Berlin, Germany: Springer; 2020.", "ArticleIdList": ["PMC7137402", "32264922"]}, {"Citation": "Sahoo A., Swain S. S., Paital B., Panda M. Combinatorial approach of vitamin C derivative and anti-HIV drug-darunavir against SARS-CoV-2. Frontiers in Bioscience-Landmark . 2022;27(1):p. 1. doi: 10.31083/j.fbl2701010.", "ArticleIdList": ["10.31083/j.fbl2701010", "35090315"]}, {"Citation": "Rudrapal M., Gogoi N., Chetia D., et al. Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: molecular docking, MD simulation and drug-likeness/ADMET studies. Saudi Journal of Biological Sciences . 2022;29(4):2432\u20132446. doi: 10.1016/j.sjbs.2021.12.018.", "ArticleIdList": ["10.1016/j.sjbs.2021.12.018", "PMC8667520", "34924801"]}, {"Citation": "Bharathi M., Sivamaruthi B. S., Kesika P., Thangaleela S., Chaiyasut C. In silico screening of potential phytocompounds from several herbs against sars-cov-2 indian delta variant B. 1.617. 2 to inhibit the spike glycoprotein trimer. Applied Sciences . 2022;12(2):p. 665. doi: 10.3390/app12020665.", "ArticleIdList": ["10.3390/app12020665"]}, {"Citation": "Singh R., Bhardwaj V. K., Sharma J., Purohit R., Kumar S. In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. Journal of traditional and complementary medicine . 2022;12(1):35\u201343. doi: 10.1016/j.jtcme.2021.05.005.", "ArticleIdList": ["10.1016/j.jtcme.2021.05.005", "PMC8172245", "34099976"]}, {"Citation": "Karimi A., Majlesi M., Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. Journal of nephropharmacology . 2015;4(1):27\u201330.", "ArticleIdList": ["PMC5297475", "28197471"]}, {"Citation": "Di Matteo G., Spano M., Grosso M., et al. Food and COVID-19: preventive/co-therapeutic strategies explored by current clinical trials and in silico studies. Foods . 2020;9(8):p. 1036. doi: 10.3390/foods9081036.", "ArticleIdList": ["10.3390/foods9081036", "PMC7466271", "32752217"]}, {"Citation": "Johansson M. A., Quandelacy T. M., Kada S., et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Network Open . 2021;4(1) doi: 10.1001/jamanetworkopen.2020.35057.2035057", "ArticleIdList": ["10.1001/jamanetworkopen.2020.35057", "PMC7791354", "33410879"]}, {"Citation": "Cao S., Gan Y., Wang C., et al. Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nature Communications . 2020;11(1):5917\u20137. doi: 10.1038/s41467-020-19802-w.", "ArticleIdList": ["10.1038/s41467-020-19802-w", "PMC7679396", "33219229"]}, {"Citation": "Heyman H. M., Meyer J. J. M. NMR-based metabolomics as a quality control tool for herbal products. South African Journal of Botany . 2012;82:21\u201332. doi: 10.1016/j.sajb.2012.04.001.", "ArticleIdList": ["10.1016/j.sajb.2012.04.001"]}, {"Citation": "Preto M., Tavares M., Sebasti\u00e3o P., Azeredo R. Determination of herb authenticity by low-field NMR. Food Chemistry . 2013;136(3-4):1272\u20131276. doi: 10.1016/j.foodchem.2012.09.045.", "ArticleIdList": ["10.1016/j.foodchem.2012.09.045", "23194523"]}, {"Citation": "Beek T. A. Low\u2010field benchtop NMR spectroscopy: status and prospects in natural product analysis. Phytochemical Analysis . 2021;32(1):24\u201337. doi: 10.1002/pca.2921.", "ArticleIdList": ["10.1002/pca.2921", "31989704"]}, {"Citation": "Peng W. K., Kong T. F., Ng C. S., et al. Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis. Nature Medicine . 2014;20(9):1069\u20131073. doi: 10.1038/nm.3622.", "ArticleIdList": ["10.1038/nm.3622", "25173428"]}, {"Citation": "Han J., Peng W. K. Reply to \u201cConsiderations regarding the micromagnetic resonance relaxometry technique for rapid label-free malaria diagnosis\u201d. Nature Medicine . 2015;21(12):1387\u20131389. doi: 10.1038/nm.3959.", "ArticleIdList": ["10.1038/nm.3959", "26646491"]}, {"Citation": "Veiga M. I., Peng W. K. Rapid phenotyping towards personalized malaria medicine. Malaria Journal . 2020;19(1):p. 68. doi: 10.1186/s12936-020-3149-4.", "ArticleIdList": ["10.1186/s12936-020-3149-4", "PMC7014641", "32046739"]}, {"Citation": "Peng W. K., Chen L., Boehm B. O., Han J., Loh T. P. Molecular phenotyping of oxidative stress in diabetes mellitus with point-of-care NMR system. Npj Aging and Mechanisms of Disease . 2020;6(1) doi: 10.1038/s41514-020-00049-0.11", "ArticleIdList": ["10.1038/s41514-020-00049-0", "PMC7536436", "33083002"]}, {"Citation": "Peng W. K., Ng T.-T., Loh T. P. Machine learning assistive rapid, label-free molecular phenotyping of blood with two-dimensional NMR correlational spectroscopy. Communications Biology . 2020;3(1):p. 535. doi: 10.1038/s42003-020-01262-z.", "ArticleIdList": ["10.1038/s42003-020-01262-z", "PMC7522972", "32985608"]}, {"Citation": "Lau W.-H., White N. J., Yeo T.-W., Gruen R. L., Pervushin K. Tracking oxidation-induced alterations in fibrin clot formation by NMR-based methods. Scientific Reports . 2021;11(1) doi: 10.1038/s41598-021-94401-3.15691", "ArticleIdList": ["10.1038/s41598-021-94401-3", "PMC8333047", "34344919"]}, {"Citation": "Peng W., Paesani D. Omics meeting Onics: towards the next generation of spectroscopic-based technologies in personalized medicine. Journal of Personalized Medicine . 2019;9(3):p. 39. doi: 10.20944/preprints202003.0226.v1.", "ArticleIdList": ["10.20944/preprints202003.0226.v1", "PMC6789736", "31374867"]}, {"Citation": "Peng W. K., Chen L., Han J. Development of miniaturized, portable magnetic resonance relaxometry system for point-of-care medical diagnosis. Review of Scientific Instruments . 2012;83(9) doi: 10.1063/1.4754296.95115", "ArticleIdList": ["10.1063/1.4754296", "23020427"]}, {"Citation": "Peng W. K. Clustering NMR: machine learning assistive rapid (pseudo) two-dimensional relaxometry mapping. Biorxiv . 2020;29:p. 2029. doi: 10.1101/2020.04.29.069195.69195", "ArticleIdList": ["10.1101/2020.04.29.069195"]}, {"Citation": "Dos Santos V. R., Goncalves V., Deng P., et al. Novel time-domain NMR-based traits for rapid, label-free Olive oils profiling. Npj Science of Food . 2022;6(1) doi: 10.1038/s41538-022-00173-z.59", "ArticleIdList": ["10.1038/s41538-022-00173-z", "PMC9746572", "36513670"]}, {"Citation": "Arun Dev Sharma I. K. Jensenone from eucalyptus essential oil as a potential inhibitor of covid 19 corona virus infection. 2020.  \n https://arxiv.org/ftp/arxiv/papers/2004/2004.00217.pdf\n."}, {"Citation": "Ben-Shabat S., Yarmolinsky L., Porat D., Dahan A. Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies. Drug delivery and translational research . 2020;10(2):354\u2013367. doi: 10.1007/s13346-019-00691-6.", "ArticleIdList": ["10.1007/s13346-019-00691-6", "PMC7097340", "31788762"]}, {"Citation": "Safa O., Hassaniazad M., Farashahinejad M., et al. Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials . 2020;21:841\u2013842. doi: 10.1186/s13063-020-04765-6.", "ArticleIdList": ["10.1186/s13063-020-04765-6", "PMC7545374", "33036662"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "22"}, {"Year": "2023", "Month": "3", "Day": "9"}, {"Year": "2023", "Month": "3", "Day": "22"}, {"Year": "2023", "Month": "5", "Day": "4", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "4", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "4", "Hour": "2", "Minute": "19"}, {"Year": "2023", "Month": "4", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["37139479", "PMC10151152", "10.1155/2023/7598307"]}}], "PubmedBookArticle": []}